Epilepsy is defined as a diverse set of neurological disorders characterized by seizures. These seizures occur due to abnormal electrical activity in the brain. Factors that may lead to epilepsy include, but are not limited to, brain trauma, gene mutations, strokes, brain cancer, and extensive drug and alcohol use. Seizures occur due to a large release of glutamate, which causes a spread of excitation throughout the brain, which propagates the electrical signal and can lead to neuronal death. Myoclonic astatic epilepsy, or Doose syndrome, is characterized by seizures that start with a myotonic nature, or rapid jerks of the muscles, followed by an atonic seizure, which is where the patient is affected with a sudden loss of muscle tone, which often results in a collapse of the body. The gene associated with myoclonic astatic epilepsy is the SNC1A gene. About 50 million people have epilepsy, with 80% of that population located in developing countries. It is possible to control epilepsy with medicine, but many cases may require surgery in order to relieve symptoms.
Myoclonic Astatic Epilepsy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Myoclonic Astatic Epilepsy below!
For more information on how to use Laverne, please read the How to Guide.
We have 384 products for the study of Myoclonic Astatic Epilepsy that can be applied to Western Blot, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.